drugset / Trial / NCT07403552
Evaluate the Pharmacokinetics, Safety, and Tolerability of NSHO-101 in Healthy Participants
RandomizedParallel-groupDouble-blindOther
Summary
The purpose of this study is to evaluate the pharmacokinetics, safety, and tolerability of NSHO-101 in Healthy Participants.
Timeline
- Start
- 2026-01-31
- Primary completion
- 2026-03
- Completion
- 2026-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NSHO-101 | Unknown | — | Oral |
Indications
No indication recorded.